Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Freedman

Showing results (501-510 of 528) with videos related to

Pageof 53
Sort By:
Oncology (Williston Park, N.Y.)|April 8, 2014
ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancerMichele Y Halyard, Eleanor E R Harris, Lisa Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort studyElena B Elkin, Michelle L Klem, Anne Marie Gonzales, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1C A Stratakis, D H Schussheim, S M Freedman, et al.
The Breast Journal|February 1, 2014
Shortened radiation therapy schedules for early-stage breast cancer: a review of hypofractionated whole-breast irradiation and accelerated partial breast irradiationSimona F Shaitelman, Atif J Khan, Wendy A Woodward, et al.
British Journal of Cancer|September 14, 2016
Breast cancer risk and protracted low-to-moderate dose occupational radiation exposure in the US Radiologic Technologists Cohort, 1983-2008D L Preston, C M Kitahara, D M Freedman, et al.
Breast Cancer Research and Treatment|April 5, 2020
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndromeAnh N Le, Joanna Harton, Heena Desai, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2007
3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumideMagda F Morton, Terrance D Barrett, Wen Yan, et al.
American Journal of Clinical Oncology|January 6, 2025
Executive Summary of the American Radium Society Appropriate Use Criteria: Regional Nodal Irradiation for Breast CancerJ Isabelle Choi, Gary M Freedman, David M Guttmann, et al.
Circulation|November 28, 2001
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarctionE J Topol, J McCarthy, S Gabriel, et al.
Frontiers in Oncology|March 20, 2023
ED visits, hospital admissions and treatment breaks in head/neck cancer patients undergoing radiotherapyShareen Patel, Benjamin J Rich, Leif-Erik D Schumacher, et al.
Pageof 53

Showing results (501-510 of 528) with videos related to

Sort By:
Pageof 53
Oncology (Williston Park, N.Y.)|April 8, 2014
ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancerMichele Y Halyard, Eleanor E R Harris, Lisa Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort studyElena B Elkin, Michelle L Klem, Anne Marie Gonzales, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1C A Stratakis, D H Schussheim, S M Freedman, et al.
The Breast Journal|February 1, 2014
Shortened radiation therapy schedules for early-stage breast cancer: a review of hypofractionated whole-breast irradiation and accelerated partial breast irradiationSimona F Shaitelman, Atif J Khan, Wendy A Woodward, et al.
British Journal of Cancer|September 14, 2016
Breast cancer risk and protracted low-to-moderate dose occupational radiation exposure in the US Radiologic Technologists Cohort, 1983-2008D L Preston, C M Kitahara, D M Freedman, et al.
Breast Cancer Research and Treatment|April 5, 2020
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndromeAnh N Le, Joanna Harton, Heena Desai, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2007
3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumideMagda F Morton, Terrance D Barrett, Wen Yan, et al.
American Journal of Clinical Oncology|January 6, 2025
Executive Summary of the American Radium Society Appropriate Use Criteria: Regional Nodal Irradiation for Breast CancerJ Isabelle Choi, Gary M Freedman, David M Guttmann, et al.
Circulation|November 28, 2001
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarctionE J Topol, J McCarthy, S Gabriel, et al.
Frontiers in Oncology|March 20, 2023
ED visits, hospital admissions and treatment breaks in head/neck cancer patients undergoing radiotherapyShareen Patel, Benjamin J Rich, Leif-Erik D Schumacher, et al.
Pageof 53